The ACR will provide comments on several provisions related to Medicare physician payment and the Quality Payment Program.
RheumPAC Donor Perks Available at ACR Convergence 2024
Registration for ACR Convergence 2024 is now open, and RheumPAC is thrilled to announce exciting perks for 2024 supporters during the conference. Contributors will have access to the RheumPAC Lounge, where they can enjoy refreshments and chat with RheumPAC Committee members and ACR staff. ACR staff are also finalizing plans for this year’s RheumPAC donor…
The ACR’s Top Legislative Priority: Reforming Medicare Reimbursement
The ACR is encouraged that lawmakers are discussing Medicare physician payment reform and continues to work to educate lawmakers about the importance of both short- and long-term policy solutions. Support grassroots efforts by messaging your lawmakers today.
‘Don’t Block Patient Access to Records,’ says HHS to Healthcare Providers
The Department of Health & Human Services has released a final rule that would penalize healthcare providers who interfere with a patient’s access to, exchange or use of their electronic health information.
APEX 2024 Winners Announced: The Rheumatologist Receives 2 Awards of Excellence
A Stepping Stone or a Headache? 2023 MIPS Value Pathway Survey Findings
A survey of providers following the first year of implementation of the new the MIPS Value Pathway reveals mixed reviews of the specialty-specific reporting pathway, with some recommendations for improvement but an overall positive experience.
Invest in RheumPAC Before a Critical Reporting Deadline
Approaching a critical Federal Election Commission reporting deadline on July 15, RheumPAC is just $976 short of its key mid-year fundraising goal.
Take Action to Modernize Prior Authorization & Streamline Access to Care
The reintroduction of the Improving Seniors’ Access to Care Act gives an opportunity to reduce administrative burden and undue delay of patient care imposed by prior authorization in Medicare Advantage plans. Contact your members of Congress today to urge them to pass this vital bill.
CAR-T Cell Therapy in Autoimmune Disease: The Next Frontier
Chimeric antigen receptor (CAR) T cell therapy has the potential to fundamentally shift the treatment of autoimmune disease. During his presentation at EULAR 2024, Georg Schett, MD, provided an overview of this treatment process and described the promising findings of the latest research.
State Copay Accumulator Legislation: An Overview
As uncertainty persists around federal policies regarding copay accumulator programs, a growing number of states are stepping in. A total of 21 states have banned the programs and others are increasing transparency requirements
- « Previous Page
- 1
- …
- 19
- 20
- 21
- 22
- 23
- …
- 319
- Next Page »